Showing results (131-140 of 233) with videos related to
Sort By:
Pageof 24
Analytical and Bioanalytical Chemistry|January 16, 2026
A machine learning-driven Raman spectroscopy approach for non-invasive diagnosis of non-puerperal mastitisYongqi Li, Haoran Zhang, Yining Jia, et al.American Journal of Physiology. Renal Physiology|December 11, 2003
Vascular localization of soluble epoxide hydrolase in the human kidneyZhigang Yu, Benjamin B Davis, Christophe Morisseau, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 23, 2020
Tim-3 promotes cell aggressiveness and paclitaxel resistance through NF-κB/STAT3 signalling pathway in breast cancer cellsYizi Cong, Yuxin Cui, Shiguang Zhu, et al.Biosensors & Bioelectronics|April 18, 2016
A "signal on" protection-displacement-hybridization-based electrochemical hepatitis B virus gene sequence sensor with high sensitivity and peculiar adjustable specificityFengqin Li, Yanmei Xu, Xiang Yu, et al.Bioresource Technology|February 24, 2022
The combination of aerobic and microaerobic promote hydrolysis and acidification of rice straw and pig manure: Balance of insoluble and soluble substrateShuyu Xiang, Yuhuan Liu, Feihu Lu, et al.Mediators of Inflammation|February 10, 2017
Periductal Mastitis: An Inflammatory Disease Related to Bacterial Infection and Consequent Immune Responses?Lu Liu, Fei Zhou, Pin Wang, et al.China CDC Weekly|May 16, 2023
Breast Cancer Awareness and Association with Frequency of Screening Among Women - China, 2020Heling Bao, Liyuan Liu, Shu Cong, et al.Annals of Medicine|July 20, 2025
Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysisLiyuan Liu, Peng Zhou, Lijuan Hou, et al.World Journal of Surgical Oncology|August 20, 2024
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in ChinaSong Wu, Li Bian, Haibo Wang, et al.Journal of Clinical Pharmacology|September 12, 2015
Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixabanMing Chang, Zhigang Yu, Andrew Shenker, et al.Pageof 24